Imunon, Inc. — Director's Dealing 2022

Oct 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2022-09-30

Reporting Person: Dentzer James E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-30	Option (right to buy)	$1.68	A	2667	Acquired	2032-09-30	Common Stock (2667)	Direct

Footnotes

F1: Represents an option grant under the Issuer's 2018 Stock Plan. The option vests in equal installments commencing January 1, 2023 and annually thereafter.